One year follow-up of patients with rhinitis medicamentosa after vasoconstrictor withdrawal

American Journal of Rhinology

Volumn 11, Issue 1, 1997, Pages 67-72

  Graf, Peter M ^a,b   Hallén, Hans ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b STOCKHOLM SÖDER HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BUDESONIDE; DECONGESTIVE AGENT; OXYMETAZOLINE;

ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; HUMAN; INTRANASAL DRUG ADMINISTRATION; MALE; RHINITIS; VASOCONSTRICTION;

EID: 0030975341     PISSN: 10506586     EISSN: None     Source Type: Journal    
DOI: 10.2500/105065897781446865     Document Type: Article

References (27)

1. Lake C. Rhinitis medicamentosa. Mayo Clinic Proc 21:367-371, 1946.
2. Kully B. The use and abuse of nasal vasoconstrictor medication. JAMA 127:307-310, 1945.
3. Feinberg S, Friedlaender S. Nasal congestion from frequent use of privine hydrochloride. JAMA 128:1095-1096, 1945.
4. Kuhn A. Evaluation of a new nasal decongestant. J Ind State Med Assoc 59:1295-1296, 1966.
5. Petruson B. Treatment with xylometazoline (Otrivin) nosedrops over a six-week period. Rhinology 19:167-172, 1981.
6. Petruson B, Hansson H-A. Function and structure of the nasal mucosa after 6 weeks' use of nose-drops. Acta Otolaryngol (Stockh) 94:563-569, 1982.
7. Rijntjes E. Nose-drop abuse, a functional and morphological study: University of Leiden, Thesis, 1985.
8. Åkerlund A, Bende M. Sustained use of xylometazoline nose drops aggravates vasomotor rhinitis. Am J Rhinol 5:157-160, 1991.
9. Graf P, Juto J-E. Decongestion effect and rebound swelling of the nasal mucosa during 4-week use of oxymetazoline. ORL 56:131-134, 1994.
10. Suh S-H, Chon K, Min Y-G, et al. Effects of topical nasal decongestants on histology of nasal respiratory mucosa in rabbits. Acta Otolaryngol (Stockh) 115:664-671, 1995.
11. Graf P, Hallén H, Juto J-E. Benzalkonium chloride in a decongestant nasal spray aggravates rhinitis medicamentosa in healthy volunteers. Clin Exp Allergy 25:395-400, 1995.
12. Graf P, Hallén H. Effect on the nasal mucosa of long-term treatment with oxymetazoline, benzalkonium chloride, and placebo nasal sprays. Laryngoscope 106:605-609, 1996.
13. Feinberg A, Feinberg S. The "nose drop nose" due to oxymetazoline (Afrin) and other topical vasoconstrictors. III Med J 140: 50-52, 1971.
14. Fleece L, Mizes J, Jolly P, Baldwin R. Rhinitis medicamentosa. Alabama J Med Sci 21:205-208, 1984.
15. Baldwin R. Rhinitis medicamentosa (An approach to treatment). J Med Assoc State Ala 47:33-35, 1977.
16. Scadding G. Rhinitis medicamentosa. Clin Exp Allergy 25:391-394, 1995.
17. Toohill R, Lehman R, Grossman T, Belson T. Rhinitis medicamentosa. Laryngoscope 91:1614-1621, 1981.
18. Walker J. Rhinitis medicamentosa. J Allergy 23:183-186, 1952.
19. Juto J-E, Lundberg C. An optical method for determining changes in mucosal congestion in the nose in man. Acta Otolaryngol (Stockh) 94:149-156, 1982.
20. Falk J, Juto J-E, Stridh G, Bylin G. Dose-response study of formaldehyde on nasal mucosa swelling. A study on residents with nasal distress at home. Am J Rhinol 8:143-146, 1994.
21. Hallén H, Graf P. Benzalkonium chloride in nasal decongestive sprays has a long-lasting adverse effect on the nasal mucosa of healthy volunteers. Clin Exp Allergy 25:401-405, 1995.
22. Graf P, Hallén H, Juto J-E. The pathophysiology and treatment of rhinitis medicamentosa. Clin Otolaryngol 20:224-229, 1995.
23. Graf P, Juto J. Sustained use of xylometazoline nasal spray shortens the decongestive response and induces rebound swelling. Rhinology 33:14-17, 1995.
24. Druce H. Nasal blood flow. Ann Allergy 71:288-291, 1993.
25. Hallén H, Juto J-E. A test for objective diagnosis of nasal hyperreactivity. Rhinology 31:23-25, 1993.
26. Graf P. Overuse of oxy- and xylometazoline nasal sprays. Changes in nasal mucosal swelling and histamine sensitivity in healthy subjects and in patients with rhinitis medicamentosa. Karolinska Institute, Thesis, 1994.
27. Hallén H, Juto J-E. An objective method to record changes in nasal reactivity during treatment of non-allergic nasal hyperreactivity. ORL 56:92-95, 1994.